Vascular endothelial growth factor and e-nitric oxide synthase-mediated regenerative response occurring upon autologous and heterologous bone grafts

International Journal of Immunopathology and Pharmacology

Volumn 22, Issue 4, 2009, Pages 1105-1116

  Tetè, Stefano ^a   Zara, S ^a   Vinci, R ^b   Zizzari, V ^a   Di Tore, U ^a   Mastrangelo, F ^a   Cataldi, A ^a   Gherlone, E ^b  

^a UNIVERSITY OF CHIETI   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Apoptotic; Bone graft; Bone remodeling; BSP; NOS; VEGF

Indexed keywords

BROMSULFOPHTHALEIN; NITRIC OXIDE SYNTHASE; PROTEIN BAX; VASCULOTROPIN;

ARTICLE; BIOCOMPATIBILITY; BONE DEFECT; BONE GRAFT; BONE REGENERATION; CALVARIA; CELL DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MANDIBULAR NERVE; MAXILLOFACIAL SURGERY; PRIORITY JOURNAL; PROTEIN EXPRESSION; XENOGRAFT;

EID: 76349084947     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200902200427     Document Type: Article

References (50)

1. Tallgren A. The continuing reduction of the residual alveolar ridges in complete denture wearers: a mixed-longitudinal study covering 25 years. J Prosthet Dent 2003; 89:427-35.
2. Ariji Y, Kuroki T, Moriguchi S, Ariji E, Kanda S. Age changes in the volume of the human maxillary sinus: a study using computed tomography. Dentomaxillofac Radiol 1994; 23:163-8.
3. Misch CE, Chiapasco M, OT Jensen. Indications for and Classification of Sinus Bone Grafts. In: Jensen OT editor. The Sinus Bone Graft. Quintessence Pubblishing Co, 2006; chapter 4.
4. Jensen J, Sindet-Pedersen S, Oliver AJ. Varying treatment strategies for reconstruction of maxillary atrophy with implants: Results in 98 patients. J Oral Maxillofac Surg 1994; 52:210-16.
5. Wood RM, Moore DL. Grafting of the maxillary sinus with intraoral harvested autogenous bone prior to implant placement. Int J Oral Maxillofac Implants 1988; 3:209-14.
6. Orsini G, Bianchi AE, Vinci R, Piattelli A. Histologic evaluation of calvarial bone in maxillary onlay bone grafts: a report of 2 cases. Int J Oral Maxillofac Implants 2003; 18:594-8.
7. Lizuka T, Smolka W, Hallermann W, Merickske-Stern R. Extensive augmentation of the alveolar ridge using autogenous calvarial split bone grafts for dental rehabilitation. Clin Oral Implants Res 2004; 15:607-15.
8. De Ieonardis D, Pecora GE. Augmentation of the maxillary sinus with calcium sulfate: one-year clinical report from a prospective longitudinal study. Int J Oral Maxillofac Implants 1999; 14:869-78.
9. Mangano C, Scarano A, Iezzi G, Orsini G, Perrotti V, Mangano F, Montini S, Piccirilli M, Piattelli A. Maxillary sinus augmentation using an engineered porous hydroxyapatite: a clinical, histological, and transmission electron microscopy study in man. J Oral Implantol 2006; 32:122-31.
10. Aguirre-Zorzano LA, Rodriguez-Tojo MJ, Aguirre-Urizar JM. Maxillary sinus lift with intraoral autologous bone and B-Tricalcium Phospate: histological and histomorphometric clinical study. Med Oral Patol Oral Cir Bucal 2007; 12:532-6.
11. Jensen OT, Shulman LB, Block MS, Iacono VJ. Report of the sinus consensus conference of 1996. Int J Oral Maxillofac Implants 1998; 13(S):11-45.
12. Lu M, Rabie ABM. Quantitative assessment of early healing of intramembranous and endochondral autogenous bone grafts using micro-computed tomography and Q-win image analyzer. Int J Oral Maxillofac Surg 2004; 33:369-76.
13. Tessier P. Autogenous bone grafts taken from the calvarium for facial and cranial applications. Clin Plast Surg 1982; 9:531-38.
14. Hwang KG, Shim KS, Yang SM, Park CJ. Partial-thickness cortical bone graft from the mandibular ramus: a non-invasive harvesting technique. J Periodontol 2008; 79:941-4.
15. Gerstenfeld LC, Chipman SD, Kelly CM, Hodgens KJ, Lee DD, Landis WJ. Collagen expression, ultrastructural assembly and mineralization in cultures of chicken embryo osteoblasts. J Cell Biol 1988; 106:979-89.
16. Chen J, Shapiro HS, Sodek J. Development expression of bone sialoprotein mRNA in rat mineralized connective tissues. J Bone Miner Res 1992; 7:987-97.
17. Esser S, Wolburg K, Wolburg H, Breier G, Kurzchalia T, Risau W. Vascular endothelial growth factor induces endothelial fenestrations in vitro. J Cell Biol 1998; 140:947-59.
18. Lammert E, Gu G, McLaughlin M, Brown D, Brekken R, Murtaugh LC, Gerber HP, Ferrara N, Melton DA. Role of VEGf-A in vascularization of pancreatic islets. Curr Biol 2003; 13:1070-74.
19. Yokomori H, Oda M, Yoshimura K, Nagai T, Ogi M, Nomura M, Ishii H. Vascular endothelial growth factor increases fenestral permeability in hepatic sinusoidal endothelial cells. Liver Int 2003; 23:467-75.
20. Darland DC, Massingham LJ, Smith SR, Piek E, Saint-Geniez M, D'Amore PA. Pericyte production of cell-associated VEGF is differentiation- dependent and is associated with endothelial survival. Dev Biol 2003; 264:275-88.
21. Shaul PW. Regulation of endothelial nitric oxide synthase: location, location, location. Annu Rev Physiol 2002; 64:749-74.
22. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmac 1991; 43:109-42.
23. Di Pietro R, Mariggio MA, Guarnieri S, Sancilio S, Giardinelli A, Di Silvestre S, Consoli A, Zauli G, Pandolfi A. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) regulates endothelial nitric oxide synthase (e-NOS) activity and its localization within the human vein endothelial cells (HUVEC) in culture. J Cell Biochem 2006; 97:782-94.
24. Radomsky MW, Moncada S. The biological and pharmacological role of nitric oxide in platelet function. Adv Exp Med Biol 1993; 344:251-64.
25. Fleming I, Busse R. Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am J Physiol Regul Integr Comp Physiol 2003; 284:R1-12
26. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998; 281:1322-26.
27. Reed JC. Cytochrome c: can't live with it - can't live without it. Cell 1997; 91:559-62.
28. Hayden MS, Ghosh S. Signaling to NF-kB. Genes Dev 2004; 18:2195-24.
29. Wong RWK, Rabie ABM. A quantitative assessment of the healing of intramembranous and endochondral autogenous bone grafts. Eur J Orthod 1999; 21:119-26.
30. Ozaki W, Buchman SR. Volume maintenance of onlay bone grafts in the craniofacial skeleton: micro-architecture versus embryologic origin. Plast Reconstr Surg 1998; 102:291-9.
31. Young MP, Carter DH, Worthington H, Korachi M, Drucker DB. Microbial analysis of bone collected during implant surgery: a clinical and laboratory study. Clin Oral Implants Res 2001; 12:95-103.
32. John HD, Wenz B. Histomorphometric analysis of natural bone mineral for maxillary sinus augmentation. Int J Oral Maxillofac Implants 2004; 19:199-207.
33. Orsini G, Scarano A, Piattelli M, Piccirilli M, Caputi S, Piattelli A. Histologic and ultrastructural analysis of regenerated bone in maxillary sinus augmentation using a porcine bone-derived biomaterial. J Periodontol 2006; 77:1984-90.
34. Hallman M, Lundgren S, Sennerby L. Histological analysis of clinical biopsies taken 6 months and 3 years after maxillary sinus floor augmentation with 80% bovine hydroxyapatite and 20% autogenous bone mixed with fibrin glue. Clin Implant Dent Relat Res 2001; 3:87-96.
35. G.S. Katsanos, A. Anogeianaki, C. Orso, S. Tetè, V. Salini, P.L. Antinolfi, G. Sabatino. Substance P: an inflammatory peptide Eur J Inflmm 2008; 6:59-64.
36. Cypher TJ, Grossman JP. Biological principles of bone graft healing. J Foot Ankle Surg 1996; 35:413-7.
37. Paolantonio M, Dolci M, Perfetti G, Sammartino G, D'Archivio D, Spoto G, Ciampoli C, De Amicis D, Tetè S. Effect of a subgingival chlorhexidine chip on the clinical parameters and the levels of alkaline phosphatase activity in gingival crevicular fluid during the non-surgical treatment of periodontitis. J Biol Regul Homeost Agents 2008; 22:63-72.
38. Ahangari G, Shamsodin N, Chavoshzadeh Z, Moghadam KA, Ghavamzadeh A, Nazarian S. Elastase II gene encoding as inflammatory molecules in acute myeloblastic leukemia. Eur J Inflmm 2008; 6:73-9.
39. D'Orlando O, Gri G, Cattaruzzi G, Merluzzi S, Betto E, Gattei V, Pucillo C. Outside inside signalling in CD40-mediated B cell activation. J Biol Regul Homeost Agents 2007; 21:49-62.
40. Virolainen P, Vuorio E, Aro HT. Gene expression at graft-host interfaces of cortical bone allografts and autografts. Clin Orthop Relat Res 1993; 297:144-9.
41. Gigante A, Torcianti M, Boldrini E, Manzotti S, Falcone G, Greco F, Mattioli-Belmonte M. Mesenchymal stem cells. J Biol Regul Homeost Agents 2008; 22:35-44.
42. Zerbo IR, Bronckers AL, de Lange G, Burger EH. Localisation of osteogenic and osteoclastic cells in porous beta-tricalcium phosphate particles used for human maxillary sinus floor elevation. Biomaterials 2005; 26:1445-51.
43. Pretorius E, Bouic PJD, Q Thebus, W Kriek. In vitro skin permeability of different terbinafine hydrochloride formulations. Eur J Inflamm 2008; 6:135-140.
44. Dasari P, Nicholson IC, Zola H. Toll-like receptors. J Biol Regul Homeost Agents 2008; 22:17-26
45. Chow KM, Rabie AB. Vascular endothelial growth pattern of endochondral bone graft in the presence of demineralized intramembranous bone matrix - quantitative analysis. Cleft Palate Craniofac J 2000; 37:385-94.
46. Mori G, Brunetti G, Colucci S, et al. Alteration of activity and survival of osteoblasts obtained from human periodontitis patients: role of TRAIL J Biol Regul Homeost Agents 2007; 21:105-114
47. Floudas CS, Yiakoumis X, Tsironi M, Aessopos A. Reversible normolipemic xanthelasma palpebrarum associated with inflammation in Castleman's disease. Eur J Inflmm 2008; 6:95-98.
48. Gilmore TD. Introduction to NF-kappaB: players, pathways, perspectives. Oncogene 2006; 25:6680-4.
49. Rogers M-L, Beare A, Zola H, Rush RA. CD 271 (P75 neurotrophin receptor). J Biol Regul Homeost Agents 2008; 22:1-6.
50. Chiorino G, Mello Grand M, Scatolini M, Ostano P. From single gene to integrative molecular concept MAPS: pitfalls and potentials of microarray technology. J Biol Regul Homeost Agents 2008; 22:7-16.